CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to create advanced nanomedicines for cancer treatment using functionalized biopolymer-based nanoparticles. It focuses on improving drug delivery to specific cancer cells and understanding the intracellular behavior of these nanoparticles to enhance therapeutic effectiveness.
Nanomedicines are defined as specifically engineered, nanosized drugs and drug delivery systems that are comprised of multiple components.
For example, polymer-drug conjugates and drug-protein conjugates are emerging as promising approaches to treating a number of diseases, including cancer.
The payloads of these nanomedicines differ widely.
However, when targeting cancer, there is a universal requirement to reach the tumour microenvironment and often to deliver the payload to a specific intrace…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
